However, considering that immune populations in gliomas are rare in general (compared with other malignancies) and especially depleted in epigenetically driven gliomas compared to IDH-WT gliomas, single-cell profiling of bulk tumors is generally only able to profile enough cells for a broad characterization. The gene discussed is IDH1; the disease is glioma.